876 results found

Due to COVID-19 pandemic, precautions needed to be taken in the field of clinical trials where it is requisite to ensure the protection of the rights, safety and wellbeing of trial participants.

At the moment, almost all countries face a global health crisis with the rapid spread of the coronavirus pandemic.

Alternative models for the reimbursement of health services have been a common phenomenon in Europe for many years.

On 24 October 2024, the Presidency of the Republic of Türkiye amended the Decree on Pricing of Pharmaceuticals ("Decree"). The amendments introduced by the Decree entered into force on 25 October 2024.

6 Ekim 2020 tarihinde, Türkiye İlaç ve Tıbbi Cihaz Kurumu ("TİTCK") "Beşeri Aşıların Klinik Dışı Değerlendirilmesine İlişkin Kılavuz"u ("Kılavuz") yayımladı. Kılavuz, ...

As a result of the pandemic of Coronavirus (COVID-19), taking into consideration the rate of contagion and cases in countries all around the world...

On 6 October 2020, Turkish Medicines and Medical Devices Agency ("Agency") has published "Guideline on Non-clinical Evaluation of Vaccines for Human Use" ("Guideline").

You are invited to our webinar "Healthcare Webinar Series – V: What awaits the Health Sector and Digital Health in 2023?", the fifth in our New Normal in Healthcare series.

In a world where borders are increasingly porous and global citizenship is valued, obtaining a second passport has become a strategic goal for many. Among the sought-after options is Turkish citizenship...

Named Patient Programs ("NPP") is one of the exceptional importation regimes of pharmaceuticals without marketing authorization ("MA") in Turkey, ...

The Social Security Institution's ("SSI") Regulation on Drug Reimbursement ("Regulation") was published in the Official Gazette no. 31934, dated 25.08.2022.

Human medicinal products are launched to market and made available for public use after going through a set of critical clinical trials ...

With the Communiqué on Amendment to the Social Security Authority Health Implementation Communiqué ("Communiqué") and the Decision of the Health...

With the relevant regulation published in the Official Gazette dated 27.05.2023 and numbered 32203, the procedures and principles regarding the conduct of clinical trials and the protection of the rights of volunteers...

Turkish Pharmaceuticals and Medical Devices Agency ("TITCK") published the Guidelines for the Classification of Diversification Applications and Variation Applications ("Guidelines") on 14 April 2022.

The Turkish Medicine and Medical Device Institution has amended requirements for notifying the local health authority about staff changes for medical device sales and promotion support.

As stated in our previous article, Turkey introduced new plain packaging rules for tobacco with the Regulation on Methods and Procedures for Manufacturing, Labelling and Control of Tobacco Products ...